• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心理教育与动机性访谈以减少复发并提高患者对抗精神病药物治疗的参与度:干预性研究

Psychoeducation and motivational interviewing to reduce relapses and increase patients' involvement in antipsychotic treatment: interventional study.

作者信息

Bröms Gabriella, Cahling Lindah, Berntsson Anders, Öhrmalm Lars

机构信息

Unit of Clinical Epidemiology, Centre for Pharmacoepidemiology, Karolinska Institutet, Stockholm, Sweden.

PRIMA Child and Adult Psychiatry, Stockholm, Sweden.

出版信息

BJPsych Bull. 2020 Dec;44(6):265-268. doi: 10.1192/bjb.2020.28.

DOI:10.1192/bjb.2020.28
PMID:32290892
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7684775/
Abstract

AIMS AND METHOD

To assess whether the combination of motivational interviewing and psychoeducation affects relapse rate and stimulates involvement of people with psychosis in their treatment. We conducted an interventional study including patients with schizophrenia or schizoaffective disorder treated with oral antipsychotics, without previous experience of long-acting injectable antipsychotics (LAIs). They were randomised to either psychoeducation with motivational interviewing or a control group. Hospital admissions 18 months before and after the intervention, and switches to LAIs 18 months after the intervention, were recorded.

RESULTS

The two groups each comprised 101 participants. Fourteen from the intervention group and seven from the control group switched to LAIs. Five in the intervention group instigated the switch themselves, compared with zero controls (P = 0.06). Fourteen in the intervention group were readmitted to hospital during follow-up, compared with 23 in the control group (P = 0.14).

CLINICAL IMPLICATIONS

Psychoeducation with motivational interviewing may increase patients' involvement in their treatment and reduce the relapse frequency.

摘要

目的与方法

评估动机性访谈与心理教育相结合是否会影响复发率,并促进精神病患者参与其治疗。我们进行了一项干预性研究,纳入了使用口服抗精神病药物治疗的精神分裂症或分裂情感性障碍患者,这些患者既往没有长效注射用抗精神病药物(LAIs)治疗经验。他们被随机分为接受动机性访谈心理教育组或对照组。记录干预前后18个月的住院情况,以及干预后18个月转为使用LAIs的情况。

结果

两组各有101名参与者。干预组有14人、对照组有7人转为使用LAIs。干预组有5人自行促成了这种转变,而对照组为零(P = 0.06)。随访期间,干预组有14人再次住院,对照组有23人(P = 0.14)。

临床意义

动机性访谈心理教育可能会增加患者对治疗的参与度,并降低复发频率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea9d/7684775/cc5172cb07d3/S2056469420000285_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea9d/7684775/cc5172cb07d3/S2056469420000285_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea9d/7684775/cc5172cb07d3/S2056469420000285_fig1.jpg

相似文献

1
Psychoeducation and motivational interviewing to reduce relapses and increase patients' involvement in antipsychotic treatment: interventional study.心理教育与动机性访谈以减少复发并提高患者对抗精神病药物治疗的参与度:干预性研究
BJPsych Bull. 2020 Dec;44(6):265-268. doi: 10.1192/bjb.2020.28.
2
First-generation antipsychotic long-acting injections v. oral antipsychotics in schizophrenia: systematic review of randomised controlled trials and observational studies.第一代抗精神病长效注射剂与口服抗精神病药物治疗精神分裂症的比较:随机对照试验和观察性研究的系统评价
Br J Psychiatry Suppl. 2009 Nov;52:S20-8. doi: 10.1192/bjp.195.52.s20.
3
The Effect of Psychoeducation Based on Motivational Interview Techniques on Medication Adherence, Hope, and Psychological Well-Being in Schizophrenia Patients.基于动机式访谈技巧的心理教育对精神分裂症患者药物依从性、希望和心理幸福感的影响。
Clin Nurs Res. 2022 Feb;31(2):202-216. doi: 10.1177/10547738211046438. Epub 2021 Oct 1.
4
The effects of psychoeducation and motivational interviewing on treatment adherence and functionality in individuals with bipolar disorder.心理教育和动机访谈对双相情感障碍患者治疗依从性和功能的影响。
Arch Psychiatr Nurs. 2023 Aug;45:89-100. doi: 10.1016/j.apnu.2023.04.026. Epub 2023 May 9.
5
Time to Rehospitalization in Patients With Schizophrenia Receiving Long-Acting Injectable Antipsychotics or Oral Antipsychotics.长效注射抗精神病药或口服抗精神病药治疗的精神分裂症患者再入院时间。
Int J Neuropsychopharmacol. 2019 Sep 1;22(9):541-547. doi: 10.1093/ijnp/pyz035.
6
[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].[精神分裂症患者护理环境的成本效益分析:长效注射制剂下非典型抗精神病药物的影响]
Encephale. 2005 Mar-Apr;31(2):235-46. doi: 10.1016/s0013-7006(05)82390-5.
7
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia: Evaluating the Evidence.长效注射用抗精神病药在精神分裂症中的应用:评估证据。
J Clin Psychiatry. 2016;77(suppl 3):1-24. doi: 10.4088/JCP.15032su1.
8
Long-acting injectable antipsychotics (LAIs) for maintenance treatment of bipolar and schizoaffective disorders: A systematic review.长效注射抗精神病药(LAIs)用于双相情感和分裂情感障碍的维持治疗:系统评价。
Eur Neuropsychopharmacol. 2019 Apr;29(4):457-470. doi: 10.1016/j.euroneuro.2019.02.003. Epub 2019 Feb 12.
9
Treatment Patterns, Healthcare Resource Utilization and Costs Among Schizophrenia Patients Treated with Long-Acting Injectable Versus Oral Antipsychotics.长效注射抗精神病药与口服抗精神病药治疗精神分裂症患者的治疗模式、医疗资源利用和成本。
Adv Ther. 2018 Nov;35(11):1994-2014. doi: 10.1007/s12325-018-0786-x. Epub 2018 Sep 29.
10
[Comparison of medical and economic benefits of antipsychotics in the treatment of schizophrenia in France].[法国抗精神病药物治疗精神分裂症的医学与经济效益比较]
Encephale. 2017 Aug;43(4):311-320. doi: 10.1016/j.encep.2016.02.021. Epub 2016 Sep 9.

本文引用的文献

1
Perceptions and knowledge of antipsychotics among mental health professionals and patients.心理健康专业人员和患者对抗精神病药物的认知与了解。
BJPsych Bull. 2017 Oct;41(5):254-259. doi: 10.1192/pb.bp.116.055483.
2
Patient and prescriber perspectives on long-acting injectable (LAI) antipsychotics and analysis of in-office discussion regarding LAI treatment for schizophrenia.患者及处方者对长效注射用抗精神病药物的看法以及关于精神分裂症长效注射治疗的门诊讨论分析
BMC Psychiatry. 2013 Oct 16;13:261. doi: 10.1186/1471-244X-13-261.
3
The effect of motivational interviewing on medication adherence and hospitalization rates in nonadherent patients with multi-episode schizophrenia.
动机性访谈对多次发作精神分裂症药物不依从患者的药物依从性和住院率的影响。
Schizophr Bull. 2013 Nov;39(6):1242-51. doi: 10.1093/schbul/sbt138. Epub 2013 Sep 26.
4
Efficacy and effectiveness of depot versus oral antipsychotics in schizophrenia: synthesizing results across different research designs.长效与口服抗精神病药治疗精神分裂症的疗效和效果:综合不同研究设计的结果。
J Clin Psychiatry. 2013 Jun;74(6):568-75. doi: 10.4088/JCP.12r08167. Epub 2013 Apr 19.
5
Treatment adherence therapy in people with psychotic disorders: randomised controlled trial.精神障碍患者的治疗依从性治疗:随机对照试验。
Br J Psychiatry. 2010 Dec;197(6):448-55. doi: 10.1192/bjp.bp.110.077289.
6
Treatment adherence in psychoses.精神疾病的治疗依从性。
Br J Psychiatry. 2010 Dec;197(6):431-2. doi: 10.1192/bjp.bp.110.083022.
7
Attitudes of patients and mental health staff to antipsychotic long-acting injections: systematic review.患者及精神卫生工作人员对抗精神病长效注射剂的态度:系统评价
Br J Psychiatry Suppl. 2009 Nov;52:S43-50. doi: 10.1192/bjp.195.52.s43.
8
Understanding and addressing adherence issues in schizophrenia: from theory to practice.理解并解决精神分裂症的依从性问题:从理论到实践。
J Clin Psychiatry. 2007;68 Suppl 14:14-9.
9
Attitudes of psychiatrists toward antipsychotic depot medication.精神科医生对抗精神病长效针剂的态度。
J Clin Psychiatry. 2006 Dec;67(12):1948-53. doi: 10.4088/jcp.v67n1216.
10
Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia.加利福尼亚州患有精神分裂症的医疗补助患者的部分依从性及再次住院风险
Psychiatr Serv. 2004 Aug;55(8):886-91. doi: 10.1176/appi.ps.55.8.886.